beta
Trial Radar AI
Clinical Trial NCT07017660 for Virtual Reality, Rigid Cystoscopy is recruiting. See the Trial Radar Card View and AI discovery tools for all the details. Or ask anything here.
One study matched filter criteria
Card View
Back to Search

Virtual Reality Application During Cystoscopy 60 Randomized Virtual

Recruiting
Clinical Trial NCT07017660 is an interventional study for Virtual Reality, Rigid Cystoscopy that is recruiting. It started on 11 June 2025 with plans to enroll 60 participants. Led by Ayten Akkaya, it is expected to complete by 1 October 2025. The latest data from ClinicalTrials.gov was last updated on 15 June 2025.
Brief Summary
This randomized controlled experimental study aimed to determine the effect of virtual reality glasses during cystoscopy on pain, anxiety and patient satisfaction.
Detailed Description
Patients in the intervention arm; In order to evaluate pain, anxiety and patient satisfaction regarding the cystoscopy procedure, the patient's pain level will be assessed with the Visual Analog Scale 10 minutes before the procedure and the patient's anxiety level will be assessed with the State Anxiety Scale. Patients will be asked to wear virtual reality glasses starting three minutes before the procedure and until...Show More
Official Title

Effect of Virtual Reality Application on Pain, Anxiety and Patient Satisfaction During Cystoscopy: A Randomized Controlled Trial

Conditions
Virtual RealityRigid Cystoscopy
Other Study IDs
  • 2025-022
NCT ID Number
NCT07017660
Start Date (Actual)
2025-06-11
Last Update Posted
2025-06-15
Completion Date (Estimated)
2025-10
Enrollment (Estimated)
60
Study Type
Interventional
PHASE
N/A
Status
Recruiting
Keywords
Cystoscopy
Pain
anxiety
satisfaction
virtual reality
Primary Purpose
Supportive Care
Design Allocation
Randomized
Interventional Model
Parallel
Masking
None (Open Label)
Arms / Interventions
Participant Group/ArmIntervention/Treatment
Othercontrol group
Routine institution procedures will be applied during the cystoscopy procedure.
No intervention
Routine institution procedures will be applied during the cystoscopy procedure.
Experimentalvirtual reality glasses
Patients will be asked to wear virtual reality glasses starting three minutes before the procedure and until the procedure is completed. The patient will be shown a video of nature scenes with the virtual reality glasses and will also be made to listen to the sounds of water and birds. Routine institution procedures will be applied during the cystoscopy procedure.
virtual reality glasses
Patients will be asked to wear virtual reality glasses starting three minutes before the procedure and until it is completed. With the virtual reality glasses, the patient will be shown a video of nature scenes and made to listen to the sounds of water and birds. Routine institutional procedures will be applied during the cystoscopy procedure.
Primary Outcome Measures
Outcome MeasureMeasure DescriptionTime Frame
Visual Analog scale
Rating is done on a scale with a 10 cm horizontal or vertical ruler and "0" means dissatisfaction and "10" means the highest level of satisfaction.
1 day
Visual Analog Scale
Grading is made with a 10 cm long horizantal or vertical ruler on the scale and "0" means no pain and "10" means the most severe pain.
1 day
Spielberg State Anxiety Scale
The scale has a four-point Likert structure consisting of 20 items, and a total score of 20-80 is obtained.
1 day
Participation Assistant
Eligibility Criteria

Eligible Ages
Adult, Older Adult
Minimum Age
18 Years
Eligible Sexes
All
  • 18 years of age and older,
  • First elective and rigid cystoscopy performed under local anesthesia,
  • No vision, hearing and perception problems,
  • Open to communication and able to speak Turkish,
  • Patients who agree to participate in the study

  • Contraindications for the procedure (lidocaine allergy, urinary tract infection, anatomical problems related to the urethra, etc.)
  • Use of any analgesic or sedative medication at least 4 hours before cystoscopy Patients who undergo manipulation such as J stent placement or removal and/or bladder biopsy.
Ayten Akkaya logoAyten Akkaya
Study Responsible Party
Ayten Akkaya, Sponsor-Investigator, Assist. Prof. Dr., Ankara Medipol University
Study Central Contact
Contact: Ayten Akkaya, PhD, +905052931663, [email protected]
Contact: Hasan N. G. Göktuğ, PhD, +9003127970000, [email protected]
1 Study Locations in 1 Countries
Ankara Etlik City Hospital, Ankara, Turkey (Türkiye)
Ankara Etlik City Hospital, Contact, +90 0 312 797 00 00, [email protected]
Hasan N. G. Göktuğ, PhD, Principal Investigator
Recruiting